Cancer Survivors Cruise Ohio River June 4 From Newport

CINCINNATI—A record 800 cancer survivors from Ohio, Kentucky and Indiana embark Sunday, June 4, from the Newport Landing, Ky., for their annual Ohio River cruise.

 

Boarding begins at noon. Cincinnati mayor Mark Mallory will declare June 4 National Survivors Day and the boat will leave the dock at 1 p.m., returning before 4 p.m.

 

The ride on BB Riverboats’ "Belle of Cincinnati” will include two hours of entertainment—plus food, free photos of every guest and prizes.

 

The event underscores that with early detection and treatment, cancer is survivable, says planning cochair Patricia Schoenung, of Jewish Hospital.

 

This year’s cruise is sold out. Online registration for next year and more information are available at www.cancersurvivorsday.org.

 

Major sponsors are UC Cancer Center, University Hospital, and the Jewish Hospital. Other support comes from Tri-Health, Mercy Anderson, the American Cancer Society, Cancer Family Care, Fort Hamilton Hospital, Dearborn County Hospital, the Leukemia and Lymphoma Society and Cincinnati Children’s Hospital Medical Center.

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.